Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-18

Clinical Trial Update: The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children [Phase 4]

View source ↗

Summary

Phase 4 trial comparing insulin glulisine to insulin aspart on breakfast postprandial glucose in prepubertal children with type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin aspart (insulin aspart)
  • Insulin glulisine (insulin glulisine)

Snippet

Sponsor: Corewell Health West | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2023-09-18